Related Experiment Video
Updated: May 4, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Mitigating GI risks associated with the use of NSAIDs
1Department of Rheumatology, The George Washington University, Washington, District of Columbia, USA.
Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause serious gastrointestinal issues. This review explores strategies to mitigate these risks, balancing anti-inflammatory benefits with patient safety.
Area of Science:
- Pharmacology
- Gastroenterology
- Internal Medicine
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- NSAIDs are associated with significant adverse effects, particularly life-threatening gastrointestinal complications.
- Gastrointestinal complications from NSAID use represent a major public health concern due to high mortality rates.
Purpose of the Study:
- To review the scope of gastrointestinal complications associated with NSAID use.
- To explore the scientific basis for risk mitigation strategies.
- To identify successful approaches for managing NSAID-related risks.
Main Methods:
- This study is a review of existing literature.
- The review focuses on the most successful risk mitigation strategies published to date.
- The methodology involves synthesizing scientific evidence on NSAID-induced gastrointestinal adverse events and their management.
Main Results:
- Various strategies have been developed to mitigate NSAID-associated risks.
- These mitigation strategies are well-studied but not entirely without limitations.
- Successful risk reduction aims to maintain the anti-inflammatory benefits of NSAIDs while minimizing harm.
Conclusions:
- Risk mitigation strategies for NSAID use are available and effective to varying degrees.
- Strategies include careful selection of specific NSAID agents.
- Combining NSAIDs with gastroprotective measures is a key approach to reduce complications.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Ulcerative Colitis in IBD
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
